Heart Failure with Reduced Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Reduced Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Ketone Pharmacokinetic Study in HFrEF [Phase 1]
Phase 1 ketone pharmacokinetic study in heart failure with reduced ejection fraction has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Developing Oral LT3 Therapy for Heart Failure - HFrEF [Phase 1, Phase 2]
The University of Pennsylvania reports that Phase 1/2 trials of an oral LT3 therapy for heart failure with reduced ejection fraction (includ…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: High Fat Diet for Cardiac Metabolic Reprogramming [NA]
Clinical trial evaluating a high-fat diet for cardiac metabolic reprogramming in patients with heart failure due to non-ischemic dilated car…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Effectiveness of CRD-740 in Heart Failure [Phase 2]
Cardurion Pharmaceuticals reports the Phase 2 trial of CRD-740 in heart failure has been terminated, with results posted.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease [Phase 4]
Phase 4 clinical trial evaluating empagliflozin for heart failure with reduced ejection fraction in patients with end-stage renal disease on…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Respiratory Sinus Arrhythmia (RSA) Pacing Post-CABG Surgery in Patients With HFrEF [NA]
Clinical trial update shows that RSA pacing after CABG in patients with heart failure with reduced ejection fraction is currently recruiting…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study
A multicenter prospective observational study in Vietnam collecting demographic, clinical, biological, treatment characteristics, and cardio…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Digoxin and Senolysis in Heart Failure and Diabetes Mellitus [Phase 2]
Phase 2 trial update investigating digoxin and senolysis for heart failure with reduced ejection fraction and type 2 diabetes mellitus; the …
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Vericiguat for Heart Failure With Reduced Ejection Fraction After Myocardial Infarction
A clinical trial update indicates a study evaluating vericiguat for heart failure with reduced ejection fraction after myocardial infarction…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction [Phase 3]
A Phase 3 study is exploring the effects of an angiotensin receptor/neprilysin inhibitor on transthyretin cardiac amyloidosis (ATTR-CM) and …
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency [Phase 4]
Phase 4 clinical trial update reporting completion of a study evaluating intravenous iron sucrose in patients with acute decompensated heart…
-
CLINICAL_TRIALS withdrawal · 2024-11-20Clinical Trial Update: TRANSFORM Heart Failure with Reduced Ejection Fraction [NA]
The TRANSFORM trial for heart failure with reduced ejection fraction has been withdrawn, with no current status reported.
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Dashboard Activated Services and Tele-Health for Heart Failure [NA]
The VA Greater Los Angeles Healthcare System completed a trial evaluating dashboard-enabled services and tele-health for heart failure with …
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Hyperkalaemia and Its Impact on Therapy with RAASi
A completed clinical trial evaluated how hyperkalemia impacts the continuation or dosing of renin-angiotensin-aldosterone system inhibitors …
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Effect of Diuretics Withdrawal in Chronic Heart Failure With Reduced Ejection Fraction [Phase 2]
Phase 2 trial evaluating the effects and safety of withdrawing diuretics in patients with chronic heart failure with reduced ejection fracti…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Novartis reports completion of a clinical trial evaluating heart failure therapy and patient outcomes in individuals with mildly reduced or …
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF) [NA]
This document updates a clinical trial evaluating optimization of heart failure medical therapy after transcatheter valve intervention in pa…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: The VERIFY Study: An Observational Study Called VERIFY to Learn More About the Use of Vericiguat in People With Chronic Heart Failure With Reduced Ejection Fraction
The VERIFY study is an observational trial by Bayer to learn more about the use of vericiguat in people with chronic heart failure with redu…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure
This clinical trial update notes ongoing recruitment for a study comparing conduction system pacing versus surgical left ventricular epicard…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure [Phase 1, Phase 2]
An update on a Phase 1/2 study examining metabolic, anabolic, and endothelial dysfunction in heart failure with reduced ejection fraction.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Uncertainty in HFrEF Patients
A completed clinical trial (NCT05632198) investigating heart failure with reduced ejection fraction has finished; the report notes uncertain…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM) [Phase 4]
A Phase 4 trial evaluating the effect of sacubitril/valsartan (an ARNI) on ventricular arrhythmias in patients with heart failure and reduce…
-
FDA approval · 2024-10-16FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (XLCare Pharmaceuticals Inc)
FDA approved an original application for sacubitril and valsartan from XLCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Does the Sequence of Heart Failure Medication Matter [NA]
A clinical trial from Aarhus University Hospital is investigating whether the sequence of starting heart failure medications affects outcome…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Benefits of Empagliflozin in Patients With Heart Failure and Reduced Ejection Fraction Without Diabetes Mellitus [Phase 4]
Phase 4 clinical trial evaluating empagliflozin in patients with heart failure with reduced ejection fraction who do not have diabetes has c…